Senior insider sale
Chief Operating Officer at KUVATRIS THERAPEUTICS, INC. — senior position signals high conviction
$40.2K
75.59K shares
What this filing means
ROME ZACHARY plans to sell 75.59K shares of KUVATRIS THERAPEUTICS, INC. valued at approximately $40.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/30/2023ACC: 0001973379-23-000140
DirectorOfficer· Chief Operating Officer
Since Aug 2022
75.59K
Shares to sell
$40.2K
Approx. market value
40K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Services Rendered
8/28/2023
40KTotal acquired40K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/28/2023 | Restricted Stock Vesting Services Rendered | 40K | — |
| Total | 40K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
30K
Market value
$16.2K
8/22/2023
—Completed
Units to sell
20K
Market value
$11.6K
8/21/2023
Planned — Approximate Date
NASDAQPlanned
Units to sell
25.59K
Market value
$12.4K
8/28/2023
Total
Units
75.59K
Value
$40.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/22/2023 | 30K | $16.2K | — | Completed |
8/21/2023 | 20K | $11.6K | — | Completed |
| Planned — Approximate Date | ||||
8/28/2023 | 25.59K | $12.4K | NASDAQ | Planned |
| Total | 75.59K | $40.2K | ||